团队式、混合式还是标准诊疗?意大利十一所医院结核病诊疗组织模式对结核病结局的影响
该多中心研究纳入2021至2024年意大利5个地区11所医院的717例泛敏感和单耐药结核病患者,比较结核病团队、混合中心和标准诊疗三种组织模式对临床及规划结局的影响。结果显示结核病团队模式治疗完成率最高、失访率最低、住院时间更短,校正分析证实该模式与更低的不完整治疗、失访和严重不良事件风险相关。
要点
- 结核病团队模式治疗完成率87.2%,高于混合中心71.6%和标准诊疗56.3%。
- 结核病团队模式失访率9.3%,低于混合中心27.2%和标准诊疗39.9%。
- 结核病团队模式住院时间中位数26天,短于标准诊疗50天。
核心结论
- 结核病专属诊疗模式与更好的结局相关,包括更少严重不良事件、更高治疗完成率和更低失访率。
- 混合模式带来中等获益,但实施结核病团队模式能确保一致的获益。
- 研究结果支持扩大结核病团队模式以加强结核病控制并符合消除目标。
研究设计与样本
- 多中心研究,纳入2021至2024年意大利5个地区11所医院诊断的所有结核病患者。
- 共纳入717例泛敏感和单耐药结核病患者。
- 中心分为三种诊疗模式:结核病团队、混合中心和标准诊疗。
- 采用混合效应回归模型校正混杂因素。
主要发现
- 治疗完成率:结核病团队327/375(87.2%),混合中心116/162(71.6%),标准诊疗89/158(56.3%)(p < 0.0001)。
- 失访率:结核病团队35/375(9.3%),混合中心44/162(27.2%),标准诊疗63/158(39.9%)(p < 0.0001)。
- 住院时间中位数:结核病团队26天(IQR 15-55),混合中心35天(IQR 22-62),标准诊疗50天(IQR 22-82)(p < 0.0001)。
- 不良事件发生率相似(p 0.54),但结核病团队和混合中心严重程度更低。
- 校正分析显示,与标准诊疗相比,结核病团队的不完整治疗风险OR 0.10(95% CI 0.03-0.30),失访风险OR 0.09(95% CI 0.04-0.23),严重不良事件风险OR 0.40(95% CI 0.17-0.95)。
临床怎么用
- 在资源允许的高收入国家或地区,可优先考虑建立结核病团队模式以改善治疗完成率和减少失访。
- 对于结核病诊疗机构,应加强结构化护理、专职门诊和主动随访以降低失访和不完整治疗风险。
- 混合模式可作为过渡或补充,但团队模式可能带来更一致的结局改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tuberculosis (TB) continues to pose challenges in high-income countries, among migrant and socioeconomically vulnerable populations. Treatment discontinuity and loss to follow up (LTFU) remain critical barriers to TB control. This study evaluated the impact of three organizational models of TB care on clinical and programmatic outcomes in Italy. METHODS: We conducted a multicentre study including all TB patients diagnosed between 2021 and 2024 in 11 hospitals in five regions. Centres were categorized into three care models: (i) TB team (structured care with trained staff, dedicated outpatient clinics, and proactive follow-up); (ii) hybrid centre (HC); and (iii) standard-of-care (SOC). Primary outcomes included hospital length of stay, incidence and severity of adverse events, treatment completion, and LTFU. Mixed-effect regression models adjusted for confounders. RESULTS: Of 717 pansusceptible and monoresistant TB patients, 375 (52.3%) were treated in TB team centres, 175 (24.4%) in HC, and 167 (23.3%) in SOC centres. Treatment completion was higher in TB team (327/375, 87.2%) vs. HC (116/162, 71.6%) and SOC centres (89/158, 56.3%) (p < 0.0001), whereas LTFU was lowest in TB team (35/375, 9.3%) vs. HC (44/162 27.2%) and SOC (63/158, 39.9%) (p < 0.0001). Hospital stay was shorter in the TB team (median 26 days, interquartile range (IQR), 15-55) and HC (35 days, IQR, 22-62) compared with SOC (50 days, IQR, 22-82) (p < 0.0001). The occurrence of adverse events was similar (p 0.54), with lower severity in the TB team and HC. Adjusted analyses confirmed lower risk of incomplete treatment (OR, 0.10; 95% CI, 0.03-0.30), LTFU (OR, 0.09; 95% CI, 0.04-0.23), and severe adverse events (OR, 0.40; 95% CI, 0.17-0.95) in the TB team vs. SOC. DISCUSSION: The TB-dedicated care model was associated with improved outcomes, fewer severe adverse events, higher treatment completion rates, and lower LTFU. Although hybrid models conferred intermediate benefit, implementation of TB care ensured consistent gains. These findings support scaling up TB team-based models to strengthen TB control and align with elimination targets.
引用
- Guido G, Di Gennaro F, Cavallin F, et al. Team-based, hybrid, or standard of care? Organizational models of tuberculosis care on tuberculosis outcomes in eleven Italian hospital. Clin Microbiol Infect. 2025. PMID: 40876575. doi:10.1016/j.cmi.2025.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。